Global Cancer Pain Market Research Report 2019

Table of Contents

Executive Summary

1 Cancer Pain Market Overview

• 1.1 Product Overview and Scope of Cancer Pain
• 1.2 Cancer Pain Segment by Type
  • 1.2.1 Global Cancer Pain Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Opioids
  • 1.2.3 Non-Steroidal Anti-Inflammatory Drugs
  • 1.2.4 Others
• 1.3 Cancer Pain Segment by Application
  • 1.3.1 Cancer Pain Consumption Comparison by Application (2014-2025)
  • 1.3.2 Paracetamol Treatment-Related Immunotherapy
  • 1.3.3 Radiotherapy
  • 1.3.4 Chemotherapy
  • 1.3.5 Hormone Therapy
• 1.4 Global Cancer Pain Market by Region
  • 1.4.1 Global Cancer Pain Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Cancer Pain Market Size
  • 1.5.1 Global Cancer Pain Revenue (2014-2025)
  • 1.5.2 Global Cancer Pain Production (2014-2025)

2 Global Cancer Pain Market Competition by Manufacturers

• 2.1 Global Cancer Pain Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Cancer Pain Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Cancer Pain Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Cancer Pain Production Sites, Area Served, Product Types
• 2.5 Cancer Pain Market Competitive Situation and Trends
  • 2.5.1 Cancer Pain Market Concentration Rate
  • 2.5.2 Cancer Pain Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Cancer Pain Production Market Share by Regions

• 3.1 Global Cancer Pain Production Market Share by Regions
• 3.2 Global Cancer Pain Revenue Market Share by Regions (2014-2019)
• 3.3 Global Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Cancer Pain Production
  • 3.4.1 North America Cancer Pain Production Growth Rate (2014-2019)
  • 3.4.2 North America Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Cancer Pain Production
  • 3.5.1 Europe Cancer Pain Production Growth Rate (2014-2019)
  • 3.5.2 Europe Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Cancer Pain Production (2014-2019)
  • 3.6.1 China Cancer Pain Production Growth Rate (2014-2019)
  • 3.6.2 China Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Cancer Pain Production (2014-2019)
  • 3.7.1 Japan Cancer Pain Production Growth Rate (2014-2019)
  • 3.7.2 Japan Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Cancer Pain Consumption by Regions

• 4.1 Global Cancer Pain Consumption by Regions
• 4.2 North America Cancer Pain Consumption (2014-2019)
• 4.3 Europe Cancer Pain Consumption (2014-2019)
• 4.4 China Cancer Pain Consumption (2014-2019)
• 4.5 Japan Cancer Pain Consumption (2014-2019)

5 Global Cancer Pain Production, Revenue, Price Trend by Type

• 5.1 Global Cancer Pain Production Market Share by Type (2014-2019)
• 5.2 Global Cancer Pain Revenue Market Share by Type (2014-2019)
• 5.3 Global Cancer Pain Price by Type (2014-2019)
• 5.4 Global Cancer Pain Production Growth by Type (2014-2019)

6 Global Cancer Pain Market Analysis by Applications

• 6.1 Global Cancer Pain Consumption Market Share by Application (2014-2019)
• 6.2 Global Cancer Pain Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Cancer Pain Business

• 7.1 BioDelivery Science
  • 7.1.1 BioDelivery Science Cancer Pain Production Sites and Area Served
  • 7.1.2 Cancer Pain Product Introduction, Application and Specification
  • 7.1.3 BioDelivery Science Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 ProStrakan Group
  • 7.2.1 ProStrakan Group Cancer Pain Production Sites and Area Served
  • 7.2.2 Cancer Pain Product Introduction, Application and Specification
  • 7.2.3 ProStrakan Group Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Teva pharmaceuticals
  • 7.3.1 Teva pharmaceuticals Cancer Pain Production Sites and Area Served
  • 7.3.2 Cancer Pain Product Introduction, Application and Specification
  • 7.3.3 Teva pharmaceuticals Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Eli-Lilly
  • 7.4.1 Eli-Lilly Cancer Pain Production Sites and Area Served
  • 7.4.2 Cancer Pain Product Introduction, Application and Specification
  • 7.4.3 Eli-Lilly Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Grunenthal Group
  • 7.5.1 Grunenthal Group Cancer Pain Production Sites and Area Served
  • 7.5.2 Cancer Pain Product Introduction, Application and Specification
  • 7.5.3 Grunenthal Group Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 GW Pharmaceuticals
  • 7.6.1 GW Pharmaceuticals Cancer Pain Production Sites and Area Served
  • 7.6.2 Cancer Pain Product Introduction, Application and Specification
  • 7.6.3 GW Pharmaceuticals Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Johnson＆Johnson
  • 7.7.1 Johnson＆Johnson Cancer Pain Production Sites and Area Served
  • 7.7.2 Cancer Pain Product Introduction, Application and Specification
  • 7.7.3 Johnson＆Johnson Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Meda Pharmaceuticals
  • 7.8.1 Meda Pharmaceuticals Cancer Pain Production Sites and Area Served
  • 7.8.2 Cancer Pain Product Introduction, Application and Specification
  • 7.8.3 Meda Pharmaceuticals Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Orexo
  • 7.9.1 Orexo Cancer Pain Production Sites and Area Served
  • 7.9.2 Cancer Pain Product Introduction, Application and Specification
  • 7.9.3 Orexo Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Sanofi
  • 7.10.1 Sanofi Cancer Pain Production Sites and Area Served
  • 7.10.2 Cancer Pain Product Introduction, Application and Specification
  • 7.10.3 Sanofi Cancer Pain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 WEX Pharmaceuticals

8 Cancer Pain Manufacturing Cost Analysis

• 8.1 Cancer Pain Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Cancer Pain
• 8.4 Cancer Pain Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Cancer Pain Distributors List
• 9.3 Cancer Pain Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Cancer Pain Market Forecast

• 11.1 Global Cancer Pain Production, Revenue Forecast
  • 11.1.1 Global Cancer Pain Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Cancer Pain Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Cancer Pain Price and Trend Forecast (2019-2025)
• 11.2 Global Cancer Pain Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Cancer Pain Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Cancer Pain Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Cancer Pain Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Cancer Pain Production, Revenue Forecast (2019-2025)
• 11.3 Global Cancer Pain Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Cancer Pain Consumption Forecast (2019-2025)
  • 11.3.2 Europe Cancer Pain Consumption Forecast (2019-2025)
  • 11.3.3 China Cancer Pain Consumption Forecast (2019-2025)
  • 11.3.4 Japan Cancer Pain Consumption Forecast (2019-2025)
• 11.4 Global Cancer Pain Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Cancer Pain Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List